NHI:NYE-National Health Investors Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 77.74

Change

0.00 (0.00)%

Market Cap

USD 3.69B

Volume

0.28M

Analyst Target

USD 61.22
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

N/A

USD 84.14B
VTR Ventas Inc

N/A

USD 27.32B
DOC Healthpeak Properties Inc

N/A

USD 15.92B
CTRE CareTrust REIT Inc.

N/A

USD 5.63B
AHR American Healthcare REIT, Inc.

N/A

USD 4.16B
LTC LTC Properties Inc

N/A

USD 1.71B
UHT Universal Health Realty Income..

N/A

USD 0.56B
CHCT Community Healthcare Trust Inc

N/A

USD 0.53B
GMRE-PA Global Medical REIT Inc

N/A

USD 0.41B
MPW Medical Properties Trust Inc

N/A

N/A

ETFs Containing NHI

SRET Global X SuperDividend® .. 4.76 % 0.59 %

N/A

USD 0.22B
DIV Global X SuperDividend U... 0.00 % 0.46 %

N/A

USD 0.65B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 39.19% 79% B- 90% A-
Dividend Return 4.83% 23% F 70% C-
Total Return 44.03% 86% B+ 91% A-
Trailing 12 Months  
Capital Gain 44.85% 79% B- 87% B+
Dividend Return 6.71% 31% F 76% C+
Total Return 51.56% 86% B+ 89% A-
Trailing 5 Years  
Capital Gain -3.52% 69% C- 41% F
Dividend Return 23.78% 38% F 71% C-
Total Return 20.26% 54% F 43% F
Average Annual (5 Year Horizon)  
Capital Gain 2.69% 73% C 44% F
Dividend Return 8.79% 60% D- 56% F
Total Return 6.10% 60% D- 89% A-
Risk Return Profile  
Volatility (Standard Deviation) 24.04% 53% F 46% F
Risk Adjusted Return 36.57% 53% F 53% F
Market Capitalization 3.69B 50% F 74% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector